Background Human papillomavirus (HPV) vaccination can prevent HPV-related illness and associated cancers, including oropharyngeal.The safety and efficacy of HPV vaccination has been well-established, but national HPV vaccination rates remain unacceptably faber-castell tamitio rollerball pen low with persistent disparities for certain populations.While vaccination has been one of the biggest public health accomplishments of the last century, vaccine hesitancy continues to grow in the United States, and remains a challenging element of low HPV vaccine uptake.
Description Oral health providers have been traditionally siloed and largely uninvolved in vaccination counseling and administration, but the COVID-19 pandemic brought oral health providers, pharmacists and other allied professions together to join in disease prevention efforts.Over 70% of oropharyngeal cancer cases are caused by HPV, placing oral health providers in a unique and critical ethical position to join in HPV prevention efforts by recommending the HPV vaccine to patients and directly administering the vaccine when appropriate.This discussion aims to (1) educate oral health providers about HPV and oropharyngeal cancer, (2) provide concrete strategies and resources gold ps5 controller skin for incorporating HPV prevention into clinical dental practice, and (3) discuss the challenges of patient vaccine hesitancy and opportunities for patient education.